# Curamir Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curamir-therapeutics

- Industry: Biotechnology
- Headquarters: Woburn, US
- Total disclosed funding: $10M
- Latest round: Series A (Sep 20, 2019)
- Investors on record: 1

## About

Founded in 2019 and based in Massachusetts, US, Curamir Therapeutics, Inc. is a biotechnology company developing miRNA-based cancer therapeutics to address chemoresistance.

## Funding rounds

- Series A, Sep 20, 2019, $10M — Delos Capital Partners

## Investors

- Delos Capital Partners (https://capitalatlas.ai/funds/delos-capital-partners) — Series A